**Abstract**

Vortioxetine, a newly approved antidepressant for the treatment of major depressive disorder has received special attention for its combination of antidepressant and pro-cognitive properties. Vortioxetine is a multimodal drug with a pharmacological profile distinct from conventional SSRIs as it works through two complementary mechanisms: 5-HT receptor activity modulation and SERT reuptake inhibition. Previous gene expression studies have suggested that vortioxetine has neuroplasticity enhancing properties; however, most of these studies were conducted in naïve animals.

Chronic mild stress (CMS) has been reported to induce an anhedonic-like state in rodents that resembles some of the symptoms of human depression. In the present study we use the CMS model to investigate molecular correlates of possible anti-anhedonic and cognitive enhancing effects of vortioxetine. Adult male Long Evans rats were exposed to 9 weeks of CMS, and treated with vortioxetine (administered in the diet) during the last 4 weeks of the stress period. Sucrose consumption tests were performed weekly during the stress and treatment periods to evaluate the anhedonic state. Cognitive functions were assessed by the social interaction and Barnes maze tests.

Our preliminary data show that the CMS paradigm reduced the sucrose consumption in a subset of the rats, indicating anhedonic-like behavior, while another subgroup of rats were resilient to the CMS. The anhedonic-like state was reversed in 70 percent of the animals in response to chronic vortioxetine treatment, while the remaining animals were resistant (non-responder rats).

To improve our understanding of the molecular mechanisms associated with the anti-anhedonic effect of vortioxetine, we are currently investigating synaptosomes prepared from the hippocampus and prefrontal cortex for synaptic alterations in proteins involved in neuroplasticity with particular focus on proteins regulating dendritic spine function and morphology.
